Klotho Therapeutics Raised $10 Million to Bottle a Longevity Protein. The Hard Part Is Still Human Proof

Klotho Therapeutics has a patented protein, a myth-sized ambition and a very human bottleneck: animal evidence is intriguing, but patients need manufacturing, dosing and trials - not mythology.